Alvotech reports record results for 2024 and provides business update

Reykjavik, iceland, march 26, 2025 (globe newswire) -- alvotech (nasdaq: alvo, or the “company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for full year 2024 and provided a summary of recent pipeline and corporate highlights. management will conduct a business update conference call and live webcast on march 27, 2024, at 8:00 am et (12:00 pm gmt).
ALVO Ratings Summary
ALVO Quant Ranking